While both the United States and Europe strive to provide excellent cancer care, their approaches differ significantly. The US often emphasizes innovative treatments, sometimes leading to increased costs. In contrast, European systems tend to prioritize proactive care and accessibility, focusing on early detection. This can result in distinct patie